vigabatrin has been researched along with Autism Spectrum Disorder in 3 studies
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The mainstay of treatment is with multiple anti-seizure medications (ASMs); however, the ASMs themselves can be associated with psychobehavioural adverse events, and effects (negative or positive) on cognition and sleep." | 2.82 | Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. ( Schubert-Bast, S; Strzelczyk, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Strzelczyk, A | 1 |
| Schubert-Bast, S | 1 |
| Moavero, R | 1 |
| Kotulska, K | 1 |
| Lagae, L | 1 |
| Benvenuto, A | 1 |
| Emberti Gialloreti, L | 1 |
| Weschke, B | 1 |
| Riney, K | 1 |
| Feucht, M | 1 |
| Krsek, P | 1 |
| Nabbout, R | 1 |
| Jansen, AC | 1 |
| Wojdan, K | 1 |
| Borkowska, J | 1 |
| Sadowski, K | 1 |
| Hertzberg, C | 1 |
| Van Schooneveld, MM | 1 |
| Samueli, S | 1 |
| Maulisovà, A | 1 |
| Aronica, E | 1 |
| Kwiatkowski, DJ | 1 |
| Jansen, FE | 1 |
| Jozwiak, S | 1 |
| Curatolo, P | 1 |
| Davis, PE | 1 |
| Peters, JM | 1 |
| Krueger, DA | 1 |
| Sahin, M | 1 |
2 reviews available for vigabatrin and Autism Spectrum Disorder
| Article | Year |
|---|---|
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Topics: Autism Spectrum Disorder; Bromides; Cannabidiol; Clobazam; Cognition; Ethosuximide; Everolimus; Felb | 2022 |
Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism.
Topics: Animals; Autism Spectrum Disorder; Brain; Epilepsy; GABA Agents; Humans; Neurons; TOR Serine-Threoni | 2015 |
1 trial available for vigabatrin and Autism Spectrum Disorder
| Article | Year |
|---|---|
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
Topics: Anticonvulsants; Autism Spectrum Disorder; Child, Preschool; Developmental Disabilities; Epilepsy; F | 2020 |